解码子宫内膜异位症中的血清素:通过肠道-生殖道微生物轴揭示其在疾病发病机制中的作用
本研究通过多组学和多部位方法探索子宫内膜异位症的机制,发现患者血清素升高,并通过增强细胞增殖和炎症促进疾病进展。肠道-生殖道微生物轴可能调控血清素水平,为发病机制提供新见解和潜在治疗靶点。
要点
- 子宫内膜异位症患者血清素水平升高,促进细胞增殖和炎症。
- Akkermansia muciniphila在患者中富集,与腹膜血清素正相关。
- 血清素通过上调IL-17/NF-κB通路促进子宫内膜异位症细胞增殖和炎症。
核心结论
- 子宫内膜异位症中血清素升高,通过增强细胞增殖和炎症促进疾病进展。
- 肠道-生殖道微生物轴可能调控血清素水平,为潜在治疗靶点。
研究设计与样本
- 横断面研究,纳入22例子宫内膜异位症患者和22例子宫肌瘤对照(手术病例,2022年10月至2023年6月)。
- 验证组额外纳入20例子宫内膜异位症患者和20例健康育龄志愿者血清。
主要发现
- 子宫内膜异位症患者中Akkermansia muciniphila显著富集,与腹膜血清素水平正相关。
- 孟德尔随机化分析将Akkermansia muciniphila和血清素与子宫内膜异位症风险升高相关联。
- 患者血清和异位内膜中血清素水平升高。
- 体外实验显示血清素促进子宫内膜异位症细胞增殖、迁移、侵袭和炎症,上调IL-17/NF-κB通路。
- 小鼠模型中血清素治疗增加病灶生长、细胞增殖和炎症。
临床怎么用
- 血清素及其受体可能作为子宫内膜异位症预防和治疗的潜在靶点。
- 针对肠道-生殖道微生物轴的干预可能调节血清素水平,为治疗提供新思路。
局限性
- 样本量有限,且ASRM分期分布和剖宫产率可能不平衡,限制普适性。
- 对照组非完全健康女性,可能低估组间差异。
- 未评估血清性激素水平,但严格纳入标准和统一手术时机以减少混杂。
- 未收集饮食信息,尽管饮食影响肠道微生物和血清素代谢。
- Akkermansia muciniphila与血清素升高的直接因果关系尚未建立,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: How can the potential mechanisms and targets of endometriosis be explored through multi-omics and multi-location approaches? SUMMARY ANSWER: This exploration of the gut-reproductive axis in patients with endometriosis found that serotonin is elevated in endometriosis and promotes disease progression through enhanced cell proliferation and inflammation. WHAT IS KNOWN ALREADY: Endometriosis is a common inflammatory disease. Recent studies indicate that peripheral serotonin, which is regulated by the gut microbiota, can promote the progression of irritable bowel syndrome and various cancers. STUDY DESIGN, SIZE, DURATION: This cross-sectional study enrolled 22 endometriosis patients and 22 control patients with uterine fibroids (surgical cases, October 2022-June 2023). Samples of vaginal secretions, endometrial tissue, peritoneal lavage fluid, feces, and ectopic lesions were collected from both groups. For validation, serum samples were added from 20 additional endometriosis patients and 20 healthy reproductive-age volunteers. PARTICIPANTS/MATERIALS, SETTING, METHODS: This study employed 16S rRNA gene sequencing to analyze the microbiota in the vagina, endometrial tissue, peritoneal fluid, and feces of patients with endometriosis and control groups, complemented by untargeted metabolomic analysis of peritoneal fluid. The results identified serotonin as a key metabolite and revealed specific bacterial species, shared between the reproductive and gastrointestinal tracts of endometriosis patients, which were significantly correlated with serotonin levels. Mendelian randomization analysis was conducted to explore the relationship between serotonin, these bacterial species, and endometriosis. Serum serotonin levels in endometriosis patients, BALB/C mouse models, and their respective controls were measured using ELISA. Immunohistochemistry and fluorescence staining were used to detect the expression of serotonin and its receptors in both ectopic and normal endometrium. The effects of serotonin on the biological behavior of various endometriosis cell models, including proliferation, migration, invasion, and apoptosis, were investigated using CCK8 assay, wound healing test, Transwell assay, apoptosis detection, ELISA, transcriptomics, and qPCR. The impact of serotonin on BALB/C mouse models was evaluated using H&E staining, flow cytometry, and ELISA. MAIN RESULTS AND THE ROLE OF CHANCE: We identified a significant enrichment of Akkermansia muciniphila (a bacterium shared by the gut and reproductive tract) in endometriosis patients, which positively correlated with peritoneal serotonin levels; Mendelian randomization analysis linked both to elevated endometriosis risk. Serotonin levels were elevated in patients' serum (using mouse models) and in ectopic endometrium, in comparison to those of controls. In vitro, serotonin boosted endometriosis cell proliferation, migration, invasion, and inflammation, with upregulated IL-17/NF-κB pathways. In mice, serotonin treatment increased lesion growth, cell proliferation, and inflammation. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: (a) The relatively limited sample size, together with potential imbalance in endometriosis ASRM stage distribution and cesarean section rates, may restrict the generalizability of our findings. In addition, due to the requirement for peritoneal lavage fluid collection, the control group could not consist of entirely healthy women, which may have resulted in a more conservative estimation of group differences. Serum sex hormone levels were not assessed; however, strict inclusion criteria and uniform surgical timing were applied to minimize hormonal confounding. Future studies incorporating cycle-phase-standardized hormone measurements may provide additional insights. (b) Dietary information was not collected in this study, despite the known influence of diet on gut microbiota composition and serotonin metabolism. (c) The direct causal relationship between Akkermansia muciniphila and elevated serotonin levels remains to be established and warrants further validation using germ-free mouse models or fecal microbiota transplantation approaches. (d) The precise mechanisms by which the gut-reproductive tract microbiota axis regulates local and systemic serotonin synthesis remain unclear and require further investigation. WIDER IMPLICATIONS OF THE FINDINGS: Our study is the first to utilize a multi-omics approach combined with a joint analysis of the female gut-reproductive tract axis across multiple loci, revealing and validating a significant increase in serotonin levels in patients with endometriosis. This change may be regulated by the gut-reproductive microbiota axis. These findings provide new insights into the pathogenesis of endometriosis and identify potential targets for prevention and treatment. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the Jilin Provincial Key Laboratory of Precision Infectious Diseases (Grant No. 20200601011JC), Key Laboratory of Health and Family Planning Commission of Jilin Province (Grant No. 3D5200117426). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. TRIAL REGISTRATION NUMBER: ChiCTR2300077490.
引用
- Wang X, Jia Y, Wang C, et al. Decoding serotonin in endometriosis: unveiling its role in disease pathogenesis via the gut-reproductive microbiota axis. Hum Reprod. 2026. PMID: 41903570. doi:10.1093/humrep/deag047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。